Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ToGA: Herceptin in advanced gastric cancer
NCT01041404Phase 3Completed
- Sponsor
- Roche
- Start
- Sep 2005
- Primary completion
- Jun 2010
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 24
01
Overview
A Phase 3 trial of trastuzumab in gastric cancer (GC), gastroesophageal junction adenocarcinoma, sponsored by Roche. Started Sep 2005; status: completed.
02
Drugs
03
Conditions
gastric cancer (GC)gastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT01041404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01041404.